GenSci134 not checked

Changchun GeneScience Pharmaceutical Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
3 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“only one dose of GenSci134 to be given, subcutaneous , 6 dose levels will be assigned.”In the company’s words, NCT07450001 on ClinicalTrials.gov
Tested for
Pediatric Growth Hormone Deficiency, Idiopathic Short Stature, Safety, Tolerability, Adult Growth Hormone Deficiency
Main trialPhase 1/2
“This study comprises two phases: Phase Ib and Phase II. Phase Ib is a multicenter, randomized, open-label, active-controlled, single-dose, dose-escalation to assess safety, tolerability, PK/PD profile, and immunogenicity of GenSci134 in children with GHD. Phase II is a multicenter, randomized, open-label, active-controlled, multiple-dose, parallel-group study to assess the efficacy and safety of multiple subcutaneous doses of GenSci134 at different levels versus Norditropin® in children with GHD. It will also evaluate PK/PD profile and immunogenicity to support dose selection for Phase III.”In the company’s words, NCT07450001 on ClinicalTrials.gov

Other drugs for Pediatric Growth Hormone Deficiency

All 5 drugs for Pediatric Growth Hormone Deficiency

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 1/2Not yet recruiting 18 Jul 2028 A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)
Phase 1/2Not yet recruiting 18 Jul 2028 A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)
Phase 1Recruiting 25 Nov 2026 A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow GenSci134

Following is part of Solo: you see every change to GenSci134 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in